Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

Key takeaways Eli Lilly has filed lawsuits against four telehealth companies—Mochi Health, Fella Health, Willow Health, and ...

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

Eli Lilly suit against Houston’s Empower Pharmacy is a battle over access to a multi-billion dollar market for weight loss ...

GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become household names in recent ...

Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and ...

"With the FDA announcing the resolution of shortages for Semaglutide (Wegovy, Ozempic) and Tirzepatide (Zepbound, Mounjaro), compounding pharmacies must halt production of these medications. This ...

While both Mounjaro (tirzepatide) and Ozempic (semaglutide) are used for blood sugar control and have shown weight loss benefits, studies suggest that Mounjaro may lead to greater weight loss in ...

Counterfeit forms of weight loss and diabetes drugs are endangering consumers, and Oklahoma General Attorney Gentner Drummond wants to take action against what he calls "bad actors" in the ...

Tirzepatide is sold under the brand names Mounjaro and Zepbound for T2D treatment and weight loss, respectively. Compounded ...

INDIANAPOLIS – The way people are accessing GLP-1 medications Semaglutide and Tirzepatide ... opposed to getting the brand name, Ozempic or Mounjaro for example, from their local pharmacy.